Dexcom, Inc. Stock Performance
as on November 6, 2025 at 2:29 am IST
Day's Low
Day's High
$58.34$60.81
1.57%
Downside
2.60%
Upside
52 Week's Low
52 Week's High
$56.45$93.254.77%
Downside
57.33%
Upside
Dexcom, Inc. share price movements today
- Previous Close
- $61.18
- Open
- $60.37
- Volume
- 7.3M
- Day's Low - High
- $58.34 - $60.81
- 52 Week Low - High
- $56.45 - $93.25
Dexcom, Inc. Historical Returns
- 1 Month Return
- -10.67 %
- 3 Month Return
- -22.41 %
- 1 Year Return
- -13.6 %
- 3 Year Return
- -48.4 %
- 5 Year Return
- -34.37 %
Dexcom, Inc. Stock Fundamentals & Key Indicators
Check Dexcom, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$23.1B
EPS (TTM)
2.0657
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.10%
PE Ratio (TTM)
32.93
Industry PE ratio
19.200384615384614
PEG Ratio
0.8466
EBITDA
1.0B
Revenue (TTM)
4.5B
Profit Margin
15.96%
Return On Equity TTM
30.64%
Dexcom, Inc. Stock Valuation
Track how Dexcom, Inc. P/E has moved over time to understand its valuation trends.
Dexcom, Inc. in the last 5 years
Lowest (46.86x)
December 31, 2024
Industry (19.20x)
November 6, 2025
Today (32.93x)
November 6, 2025
Highest (175.15x)
September 30, 2021
Today’s Price to Earnings Ratio: 32.93x
Dexcom, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Dexcom, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $23.1B | -34.37% | 32.93 | 15.96% | |
| BUY | $146.5B | 177.03% | 52.86 | 14.43% | |
| BUY | $138.7B | 67.57% | 47.15 | 12.07% | |
| BUY | $218.8B | 8.84% | 15.55 | 31.88% | |
| BUY | $48.6B | 6.16% | 36.17 | 23.25% |
Stock Returns calculator for Dexcom, Inc. Stock including INR - Dollar returns
The Dexcom, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dexcom, Inc. investment value today
Current value as on today
₹91,738
Returns
Returns from Dexcom, Inc. Stock
Dollar Returns*
₹5,351 (+5.35%)
Analyst Recommendation on Dexcom, Inc. Stock
Based on 30 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 30 analysts, 86.67% of analysts recommend a 'BUY' rating for Dexcom, Inc.. Average target price of $87
Dexcom, Inc. Share Price Target
Get share price movements and forecasts by analysts on Dexcom, Inc..
What analysts predicted
31.87%UPSIDE
Target Price
$87
Current Price
$59.27
Analyzed by
30 Analysts
Target
$87.00
Dexcom, Inc. target price $87, a slight upside of 31.87% compared to current price of $59.27. According to 30 analysts rating.
Dexcom, Inc. Stock’s Investor Sentiment and Interest
Investment in Dexcom, Inc. Shares on INDmoney has grown by 2.24% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:2.24% versus previous 30 day period
Search interest for Dexcom, Inc. Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:71% versus previous 30 day period
Dexcom, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Dexcom, Inc. Annual Profit & Loss
All numbers in Millions USD
Dexcom, Inc. Quarterly Cash Flow
All numbers in Millions USD
Dexcom, Inc. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Dexcom, Inc. Stock
Check out the Mutual Funds with significant holdings in Dexcom, Inc..
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.04607% | 3111 |
 ICICI Prudential NASDAQ 100 Index Fund Direct Growth | 0.14143% | 6022 |
 Aditya Birla Sun Life International Equity Fund Direct Plan Growth | 0.71848% | 3200 |
Global Institutional Holdings in Dexcom, Inc.
Dexcom, Inc. News & Key Events
Today's Timeline - 31 October
Fri, 02:26 PM
-Analysts maintain Buy rating on DexCom, citing strong growth prospects despite recent stock weakness.
Fri, 09:31 PM
-Class action lawsuit filed against DexCom for alleged securities law violations related to G6 and G7 devices.
Fri, 10:19 PM
-DexCom stock falls 16% after executives indicate 2026 revenue forecast may miss Wall Street expectations.
Today's Timeline - 31 October
Fri, 11:23 PM
-DexCom reports Q3 earnings beat but shares drop 12.8% in after-hours trading due to revenue forecast concerns.
Insights on Dexcom, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 105.4M → 283.8M (in $), with an average increase of 39.0% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.03B → 1.20B (in $), with an average increase of 7.4% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Edwards Lifesciences Corp. has given 28.0% return, outperforming this stock by 38.8%
- NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 22.8% return, outperforming this stock by 69.5%
NEGATIVE IMPACTPrice Dip
In the last 7 days, DXCM stock has moved down by -10.3%
About Dexcom, Inc.
| Organisation | Dexcom, Inc. |
| Headquarters | 6340 Sequence Drive, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Mr. Jacob Steven Leach |
| E-voting on shares | Click here to vote |
Key Management of Dexcom, Inc.
Name | Title |
|---|---|
Mr. Girish Naganathan | Executive VP & CTO |
Mr. Sean Christensen | Vice President of Finance and Investor Relations |
Ms. Leverne Marsh | Executive Vice President of Marketing |
Mr. Donald M. Abbey | Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs |
Mr. Michael Jon Brown | Executive VP & Chief Legal Officer |
Mr. Kevin Ronald Sayer | Executive Chairman & CEO (Leave of Absence) |
Mr. Jereme M. Sylvain CPA | Executive VP, CFO & Chief Accounting Officer |
Ms. Sadie M. Stern | Executive VP & Chief Human Resources Officer |
Mr. Matthew Dolan | Executive Vice President of Strategy & Corporate Development |
Mr. Jacob Steven Leach | Interim CEO, President & COO |
FAQs
What is Dexcom, Inc. share price today?
Dexcom, Inc. share price today is $59.27 as on at the close of the market. Dexcom, Inc. share today touched a day high of $60.81 and a low of $58.34.
What is the 52 week high and 52 week low for Dexcom, Inc. share?
Dexcom, Inc. share touched a 52 week high of $93.25 on and a 52 week low of $56.45 on . Dexcom, Inc. stock price today i.e. is closed at $59.27,which is 36.44% down from its 52 week high and 5.00% up from its 52 week low.
What is Dexcom, Inc.'s market capitalisation today?
Dexcom, Inc. market capitalisation is $0.02T as on .
How to invest in Dexcom, Inc. Stock (DXCM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Dexcom, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dexcom, Inc. Shares that will get you 0.0253 shares as per Dexcom, Inc. share price of $59.27 per share as on November 6, 2025 at 2:29 am IST.
What is the minimum amount required to buy Dexcom, Inc. Stock (DXCM) from India?
Indian investors can start investing in Dexcom, Inc. (DXCM) shares with as little as ₹88.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in Dexcom, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dexcom, Inc. share’s latest price of $59.27 as on November 6, 2025 at 2:29 am IST, you will get 0.1687 shares of Dexcom, Inc.. Learn more about
fractional shares .
What are the returns that Dexcom, Inc. has given to Indian investors in the last 5 years?
Dexcom, Inc. stock has given -34.37% share price returns and 20.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?